15	Patient initially presented in 1991 with cervical lymphadenopathy , was treated with MACE / CytaBOM , and did well until 1997 , when he received six cycles of fludarabine for progressive disease .|fludarabine[881,892]|||||||||C0059985|24698|24698|fludarabine
16	In November , 2001 , he progressed to leukemic phase , received Rituxan and CVP .|Rituxan[983,990]||||||||||226754|121191|rituximab
17	Started Campath in July , 2001 , complicated by lymphopenia / neutropenia and CMV infection , and underwent MUD stem cell transplant in December , 2002 .|Campath[1009,1016]|||||||||C0939276|284679|117055|alemtuzumab
19	He was again treated with Campath , had recurrent fever in association with sinus symptoms , with CT scan showing left maxillary sinusitis in association with new skin nodules on right elbow and buttocks .|Campath[1321,1328]|||||||||C0939276|284679|117055|alemtuzumab
21	ID consult was obtained and he was initially treated with azithromycin , itraconazole , and pentamidine , with progression of skin infection .|azithromycin[1802,1814]|||||||||C0052796|18631|18631|azithromycin
21	ID consult was obtained and he was initially treated with azithromycin , itraconazole , and pentamidine , with progression of skin infection .|itraconazole[1817,1829]|||||||||C0064113|28031|28031|itraconazole
21	ID consult was obtained and he was initially treated with azithromycin , itraconazole , and pentamidine , with progression of skin infection .|pentamidine[1836,1847]|||||||||C0030863|7994|7994|pentamidine
22	Subsequent discontinuance of azithromycin , trial of 5-FC , with increasing neutropenia requiring discontinuance , change if itraconazole to voriconazole , given continued neutropenia , and trial of sulfadiazine , discontinued for increasing ARS .|azithromycin[1916,1928]|||||||||C0052796|18631|18631|azithromycin
22	Subsequent discontinuance of azithromycin , trial of 5-FC , with increasing neutropenia requiring discontinuance , change if itraconazole to voriconazole , given continued neutropenia , and trial of sulfadiazine , discontinued for increasing ARS .|5 - FC[1940,1944]||||||||||4451|4451|flucytosine
22	Subsequent discontinuance of azithromycin , trial of 5-FC , with increasing neutropenia requiring discontinuance , change if itraconazole to voriconazole , given continued neutropenia , and trial of sulfadiazine , discontinued for increasing ARS .|voriconazole[2028,2040]|||||||||C0393080|121243|121243|voriconazole
22	Subsequent discontinuance of azithromycin , trial of 5-FC , with increasing neutropenia requiring discontinuance , change if itraconazole to voriconazole , given continued neutropenia , and trial of sulfadiazine , discontinued for increasing ARS .|itraconazole[2012,2024]|||||||||C0064113|28031|28031|itraconazole
22	Subsequent discontinuance of azithromycin , trial of 5-FC , with increasing neutropenia requiring discontinuance , change if itraconazole to voriconazole , given continued neutropenia , and trial of sulfadiazine , discontinued for increasing ARS .|sulfadiazine[2086,2098]|||||||||C0038675|10171|10171|sulfadiazine
23	Patient was maintained on p.o. voriconazole and IV pentamidine , with pentamidine nasal washings , with re-CT of sinuses near end of stay showing no change in disease burden .|voriconazole[2166,2178]|||||p.o.[2161,2165]||||C1509968|477141|121243|voriconazole
23	Patient was maintained on p.o. voriconazole and IV pentamidine , with pentamidine nasal washings , with re-CT of sinuses near end of stay showing no change in disease burden .|pentamidine[2186,2197]|||||IV[2183,2185]||||C0030863|7994|7994|pentamidine
23	Patient was maintained on p.o. voriconazole and IV pentamidine , with pentamidine nasal washings , with re-CT of sinuses near end of stay showing no change in disease burden .|pentamidine[2205,2216]|||||||||C0030863|7994|7994|pentamidine
24	He has had recurrent CMB infection in the setting of Campath therapy , requiring IV Foscarnet therapy during stay , with inability to tolerate valganciclovir maintenance suppression subsequently due to increasing ARS .|Campath[2364,2371]|||||||||C0939276|284679|117055|alemtuzumab
24	He has had recurrent CMB infection in the setting of Campath therapy , requiring IV Foscarnet therapy during stay , with inability to tolerate valganciclovir maintenance suppression subsequently due to increasing ARS .|Foscarnet[2395,2404]|||||IV[2392,2394]||||C0070895|33562|33562|foscarnet
24	He has had recurrent CMB infection in the setting of Campath therapy , requiring IV Foscarnet therapy during stay , with inability to tolerate valganciclovir maintenance suppression subsequently due to increasing ARS .|valganciclovir[2454,2468]|||||||||C0909381|275891|275891|valganciclovir
26	Patient experienced acute renal failure on chronic renal insufficiency , with previous baseline creatinine 1.6 , felt to be due to medication toxicity , requiring Kayexalate and Phoslo to manage electrolytes , but never any need for hemodialysis , with mild improvement of creatinine by discharge , with|Kayexalate[2738,2748]||||||||||51670|56512|sodium polystyrene sulfonate
26	Patient experienced acute renal failure on chronic renal insufficiency , with previous baseline creatinine 1.6 , felt to be due to medication toxicity , requiring Kayexalate and Phoslo to manage electrolytes , but never any need for hemodialysis , with mild improvement of creatinine by discharge , with|Phoslo[2753,2759]|||||||||C0722621|219236|214342|calcium acetate
28	Patient struggled with GVHD , with extensive skin involvement , taking Cellcept , prednisone and cyclosporine at time of last admission .|Cellcept[2999,3007]||||||||||152633|68149|mycophenolate mofetil
28	Patient struggled with GVHD , with extensive skin involvement , taking Cellcept , prednisone and cyclosporine at time of last admission .|prednisone[3010,3020]|||||||||C0032952|8640|8640|prednisone
28	Patient struggled with GVHD , with extensive skin involvement , taking Cellcept , prednisone and cyclosporine at time of last admission .|cyclosporine[3025,3037]|||||||||C0010592|3008|3008|ciclosporin
29	Cellcept was discontinued in the setting of infection , but attempts to decrease prednisone or cyclosporine were unsuccessful .|Cellcept[3066,3074]||||||||||152633|68149|mycophenolate mofetil
29	Cellcept was discontinued in the setting of infection , but attempts to decrease prednisone or cyclosporine were unsuccessful .|prednisone[3147,3157]|||||||||C0032952|8640|8640|prednisone
29	Cellcept was discontinued in the setting of infection , but attempts to decrease prednisone or cyclosporine were unsuccessful .|cyclosporine[3161,3173]|||||||||C0010592|3008|3008|ciclosporin
35	Refractory CLL with bone marrow involvement , status post MUD , mini-allo stem cell transplant , December , 2002 , Acanthamoeba infection of skin and sinuses , recently treated with IV pentamidine and p.o. voriconazole , history of recurrent CMB infection , recent ARS on CRI , thought due to medication|allo[3839,3843]||||||||||||
35	Refractory CLL with bone marrow involvement , status post MUD , mini-allo stem cell transplant , December , 2002 , Acanthamoeba infection of skin and sinuses , recently treated with IV pentamidine and p.o. voriconazole , history of recurrent CMB infection , recent ARS on CRI , thought due to medication|pentamidine[3955,3966]|||||IV[3952,3954]||||C0030863|7994|7994|pentamidine
35	Refractory CLL with bone marrow involvement , status post MUD , mini-allo stem cell transplant , December , 2002 , Acanthamoeba infection of skin and sinuses , recently treated with IV pentamidine and p.o. voriconazole , history of recurrent CMB infection , recent ARS on CRI , thought due to medication|voriconazole[3976,3988]|||||p.o.[3971,3975]||||C1509968|477141|121243|voriconazole
38	Graft versus host disease , recently on cyclosporine 50 b.i.d. and prednisone 60 q.d.|cyclosporine[4237,4249]|||50[4250,4252]|||b.i.d.[4253,4259]|||C0985268|315752|3008|ciclosporin
38	Graft versus host disease , recently on cyclosporine 50 b.i.d. and prednisone 60 q.d.|prednisone[4264,4274]|||60[4275,4277]|||q.d .[4278,4282]|||C0032952|8640|8640|prednisone
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|Pentamidine[4327,4338]|||300mg[4339,4345]||IV[4346,4348]|q. 36 hours[4349,4360]||||861601|7994|pentamidine
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|sterile water[4404,4417]|||6ml[4396,4400]|||q.d.[4418,4422]|||C0359299|107129|107129|water, sterile
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|Pentamidine[4363,4374]||nasal wash[4375,4385]|60mg[4386,4391]||||||C2720044|861664|7994|pentamidine
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|voriconazole 200[4425,4441]|||||p.o.[4445,4449]|b.i.d.[4450,4456]|||C1165011|349434|121243|voriconazole
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|acyclovir[4459,4468]|||400mg[4469,4475]||p.o.[4476,4480]|b.i.d.[4481,4487]||||197311|281|acyclovir
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|cyclosporine[4490,4502]|||50mg[4503,4508]||p.o.[4509,4513]|b.i.d.[4514,4520]|||C0705524|205168|3008|ciclosporin
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|prednisone[4523,4533]|||60mg[4534,4539]||p.o.[4540,4544]|q.d.[4545,4549]|||C1247651|373583|8640|prednisone
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|GCSF[4552,4556]|||480mcg[4557,4564]||IV[4565,4567]|q.d.[4568,4572]||||||
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|Epogen[4575,4581]|||40 , 000[4582,4588]||subcu[4595,4600]|q. week[4601,4608]|||C0716549|213474|105694|epoetin alfa,recombinant
41	Pentamidine 300 mg IV q. 36 hours , Pentamidine nasal wash 60 mg per 6 ml of sterile water q.d. , voriconazole 200 mg p.o. b.i.d. , acyclovir 400 mg p.o. b.i.d. , cyclosporine 50 mg p.o. b.i.d. , prednisone 60 mg p.o. q.d. , GCSF 480 mcg IV q.d. , Epogen 40,000 units subcu q. week , Protonix 40 mg|Protonix[4611,4619]|||40mg[4620,4625]||||||C1588007|542447|40790|pantoprazole
42	q.d. , Simethicone 80 mg p.o. q. 8 , nitroglycerin paste 1 &quot; q. 4 h. p.r.n. , flunisolide nasal inhaler , 2 puffs q. 8 , OxyCodone 10-15 mg p.o. q. 6 p.r.n. , Sudafed 30 mg q. 6 p.o. p.r.n. , Fluconazole 2% cream b.i.d. to erythematous skin lesions , Ditropan 5 mg p.o. b.i.d. , Tylenol 650|Simethicone[4633,4644]|||80mg[4645,4650]||p.o.[4651,4655]|q.d.[4626,4630]|||C0785602|245042|9796|simethicone
42	q.d. , Simethicone 80 mg p.o. q. 8 , nitroglycerin paste 1 &quot; q. 4 h. p.r.n. , flunisolide nasal inhaler , 2 puffs q. 8 , OxyCodone 10-15 mg p.o. q. 6 p.r.n. , Sudafed 30 mg q. 6 p.o. p.r.n. , Fluconazole 2% cream b.i.d. to erythematous skin lesions , Ditropan 5 mg p.o. b.i.d. , Tylenol 650|nitroglycerin[4663,4676]||||||q. 4 h.[4692,4699]||p.r.n.[4700,4706]|C0017887|4917|4917|glyceryl trinitrate
42	q.d. , Simethicone 80 mg p.o. q. 8 , nitroglycerin paste 1 &quot; q. 4 h. p.r.n. , flunisolide nasal inhaler , 2 puffs q. 8 , OxyCodone 10-15 mg p.o. q. 6 p.r.n. , Sudafed 30 mg q. 6 p.o. p.r.n. , Fluconazole 2% cream b.i.d. to erythematous skin lesions , Ditropan 5 mg p.o. b.i.d. , Tylenol 650|flunisolide nasal[4709,4726]||||2 puffs[4737,4744]||||||91401|25120|flunisolide
42	q.d. , Simethicone 80 mg p.o. q. 8 , nitroglycerin paste 1 &quot; q. 4 h. p.r.n. , flunisolide nasal inhaler , 2 puffs q. 8 , OxyCodone 10-15 mg p.o. q. 6 p.r.n. , Sudafed 30 mg q. 6 p.o. p.r.n. , Fluconazole 2% cream b.i.d. to erythematous skin lesions , Ditropan 5 mg p.o. b.i.d. , Tylenol 650|OxyCodone[4752,4761]|||10 - 15mg[4762,4770]||p.o.[4771,4775]|||p.r.n.[4781,4787]||1049683|7804|oxycodone
42	q.d. , Simethicone 80 mg p.o. q. 8 , nitroglycerin paste 1 &quot; q. 4 h. p.r.n. , flunisolide nasal inhaler , 2 puffs q. 8 , OxyCodone 10-15 mg p.o. q. 6 p.r.n. , Sudafed 30 mg q. 6 p.o. p.r.n. , Fluconazole 2% cream b.i.d. to erythematous skin lesions , Ditropan 5 mg p.o. b.i.d. , Tylenol 650|Sudafed[4790,4797]|||30mg[4798,4803]||p.o.[4809,4813]|||p.r.n.[4814,4820]|C0714152|1049529|8896|pseudoephedrine
42	q.d. , Simethicone 80 mg p.o. q. 8 , nitroglycerin paste 1 &quot; q. 4 h. p.r.n. , flunisolide nasal inhaler , 2 puffs q. 8 , OxyCodone 10-15 mg p.o. q. 6 p.r.n. , Sudafed 30 mg q. 6 p.o. p.r.n. , Fluconazole 2% cream b.i.d. to erythematous skin lesions , Ditropan 5 mg p.o. b.i.d. , Tylenol 650|Fluconazole[4823,4834]||cream[4838,4843]||||b.i.d.[4844,4850]|||C0016277|4450|4450|fluconazole
42	q.d. , Simethicone 80 mg p.o. q. 8 , nitroglycerin paste 1 &quot; q. 4 h. p.r.n. , flunisolide nasal inhaler , 2 puffs q. 8 , OxyCodone 10-15 mg p.o. q. 6 p.r.n. , Sudafed 30 mg q. 6 p.o. p.r.n. , Fluconazole 2% cream b.i.d. to erythematous skin lesions , Ditropan 5 mg p.o. b.i.d. , Tylenol 650|Ditropan[4882,4890]|||5mg[4891,4895]||p.o.[4896,4900]|b.i.d.[4901,4907]|||C0543049|863665|32675|oxybutynin
42	q.d. , Simethicone 80 mg p.o. q. 8 , nitroglycerin paste 1 &quot; q. 4 h. p.r.n. , flunisolide nasal inhaler , 2 puffs q. 8 , OxyCodone 10-15 mg p.o. q. 6 p.r.n. , Sudafed 30 mg q. 6 p.o. p.r.n. , Fluconazole 2% cream b.i.d. to erythematous skin lesions , Ditropan 5 mg p.o. b.i.d. , Tylenol 650|Tylenol[4910,4917]|||650[4918,4921]||||||C1739190|646457|161|paracetamol
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Ambien[4947,4953]|||||p.o.[4925,4929]|q. 4 h.[4930,4937]||p.r.n.[4938,4944]|C3224788|1170672|39993|zolpidem
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Neurontin[4984,4993]|||200mg[5011,5017]|||q. p.m.[5018,5025]|||C0678176|196498|25480|gabapentin
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Neurontin[4984,4993]|||100mg[4994,5000]|||q. a.m.[5001,5008]|||C1596318|563877|25480|gabapentin
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Aquaphor[5028,5036]||cream[5037,5042]||||b.i.d.[5043,5049]||p.r.n.[5050,5056]|C0718635|1052951|8091|petrolatum,white
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Lotrimin[5059,5067]||cream[5071,5076]||||b.i.d.[5077,5083]||||405182|2623|clotrimazole
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Dulcolax[5094,5102]|||5 - 10mg[5103,5110]||p.o.[5111,5115]|q.d.[5116,5120]||p.r.n.[5121,5127]|C0711396|209613|1596|bisacodyl
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Phoslo[5130,5136]|||667mg[5137,5143]||p.o.[5144,5148]|t.i.d.[5149,5155]||||209011|214342|calcium acetate
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Peridex[5158,5165]||mouthwash[5192,5201]|0.12[5166,5170]||p.o.[5180,5184]|b.i.d.[5185,5191]|||C1691396|834135|2358|chlorhexidine
43	mg p.o. q. 4 h. p.r.n. , Ambien 5-10 mg p.o. q. h.s. p.r.n. , Neurontin 100 mg q. a.m. , 200 mg q. p.m. , Aquaphor cream b.i.d. p.r.n. , Lotrimin 1% cream b.i.d. to feet , Dulcolax 5-10 mg p.o. q.d. p.r.n. , Phoslo 667 mg p.o. t.i.d. , Peridex 0.12% , 15 ml p.o. b.i.d. mouthwash , Benadryl 25-|Benadryl[5204,5212]|||25[5213,5215]||||||C2955099|1049631|3498|diphenhydramine
44	50 mg q. 4-6 h. p.r.n. pruritus , Sarna cream q.d. p.r.n. pruritus , Nystatin 5 ml p.o. q.i.d. swish and !  spit , folate 1 mg p.o. q.d. , vitamin E 400 units p.o. q.d. , Haldol 2 mg IV q. 6 p.r.n. agitation , Colace 100 mg b.i.d. , Senna 2 tablets p.o. b.i.d.|Sarna[5250,5255]|||50mg[5216,5221]|||q. 4 - 6 h.[5222,5231]||p.r.n.[5232,5238]||492513|1952|camphor
44	50 mg q. 4-6 h. p.r.n. pruritus , Sarna cream q.d. p.r.n. pruritus , Nystatin 5 ml p.o. q.i.d. swish and !  spit , folate 1 mg p.o. q.d. , vitamin E 400 units p.o. q.d. , Haldol 2 mg IV q. 6 p.r.n. agitation , Colace 100 mg b.i.d. , Senna 2 tablets p.o. b.i.d.|Nystatin[5285,5293]|||5ml[5294,5298]||p.o.[5299,5303]|q.i.d.[5304,5310]||||312055|7597|nystatin
44	50 mg q. 4-6 h. p.r.n. pruritus , Sarna cream q.d. p.r.n. pruritus , Nystatin 5 ml p.o. q.i.d. swish and !  spit , folate 1 mg p.o. q.d. , vitamin E 400 units p.o. q.d. , Haldol 2 mg IV q. 6 p.r.n. agitation , Colace 100 mg b.i.d. , Senna 2 tablets p.o. b.i.d.|folate[5331,5337]|||1mg[5338,5342]||p.o.[5343,5347]|q.d.[5348,5352]||||310410|4511|folic acid
44	50 mg q. 4-6 h. p.r.n. pruritus , Sarna cream q.d. p.r.n. pruritus , Nystatin 5 ml p.o. q.i.d. swish and !  spit , folate 1 mg p.o. q.d. , vitamin E 400 units p.o. q.d. , Haldol 2 mg IV q. 6 p.r.n. agitation , Colace 100 mg b.i.d. , Senna 2 tablets p.o. b.i.d.|vitamin E[5355,5364]|||400[5365,5368]||p.o.[5375,5379]|q.d.[5380,5384]|||C0981118|313717|11256|tocopherol (vit e)
44	50 mg q. 4-6 h. p.r.n. pruritus , Sarna cream q.d. p.r.n. pruritus , Nystatin 5 ml p.o. q.i.d. swish and !  spit , folate 1 mg p.o. q.d. , vitamin E 400 units p.o. q.d. , Haldol 2 mg IV q. 6 p.r.n. agitation , Colace 100 mg b.i.d. , Senna 2 tablets p.o. b.i.d.|Haldol[5387,5393]|||2mg[5394,5398]||IV[5399,5401]|||p.r.n.[5407,5413]|C1599223|566797|5093|haloperidol
44	50 mg q. 4-6 h. p.r.n. pruritus , Sarna cream q.d. p.r.n. pruritus , Nystatin 5 ml p.o. q.i.d. swish and !  spit , folate 1 mg p.o. q.d. , vitamin E 400 units p.o. q.d. , Haldol 2 mg IV q. 6 p.r.n. agitation , Colace 100 mg b.i.d. , Senna 2 tablets p.o. b.i.d.|Colace[5426,5432]|||100mg[5433,5439]|||b.i.d.[5440,5446]||||1247755|82003|docusate
44	50 mg q. 4-6 h. p.r.n. pruritus , Sarna cream q.d. p.r.n. pruritus , Nystatin 5 ml p.o. q.i.d. swish and !  spit , folate 1 mg p.o. q.d. , vitamin E 400 units p.o. q.d. , Haldol 2 mg IV q. 6 p.r.n. agitation , Colace 100 mg b.i.d. , Senna 2 tablets p.o. b.i.d.|Senna[5449,5454]||||2 tablets[5455,5464]|p.o.[5465,5469]|b.i.d[5470,5475]||||373859|36387|sennosides
80	Infectious disease consult was obtained and recommendation was to switch from voriconazole to itraconazole , on which there was more existing data on treatment of Acanthamoeba infection .|itraconazole[8037,8049]|||||||||C0064113|28031|28031|itraconazole
80	Infectious disease consult was obtained and recommendation was to switch from voriconazole to itraconazole , on which there was more existing data on treatment of Acanthamoeba infection .|voriconazole[8021,8033]|||||||||C0393080|121243|121243|voriconazole
81	Pentamidine intravenous and nasal washings were continued .|Pentamidine[8131,8142]|||||intravenous[8143,8154]||||C0030863|7994|7994|pentamidine
84	Idiosyncratic reaction to cyclosporine was considered as cause for cerebritis , and cyclosporine was discontinued .|cyclosporine[8744,8756]|||||||||C0010592|3008|3008|ciclosporin
84	Idiosyncratic reaction to cyclosporine was considered as cause for cerebritis , and cyclosporine was discontinued .|cyclosporine[8802,8814]|||||||||C0010592|3008|3008|ciclosporin
87	A single blood culture positive for coagulase negative Staphylococcus was treated with a course of vancomycin in the setting of a PICC line and a chest x-ray on November 20 indicating possible developing pneumonia , resulted in a course of levofloxacin , for both possible pneumonia , as well as treatment|vancomycin[9170,9180]|||||||||C0042313|11124|11124|vancomycin
87	A single blood culture positive for coagulase negative Staphylococcus was treated with a course of vancomycin in the setting of a PICC line and a chest x-ray on November 20 indicating possible developing pneumonia , resulted in a course of levofloxacin , for both possible pneumonia , as well as treatment|levofloxacin[9311,9323]|||||||||C0282386|82122|82122|levofloxacin
94	Pentamidine , itraconazole , Levaquin , acyclovir and GCSF were discontinued , along with other medications nonessential to patient &apos;s comfort .|Pentamidine[10193,10204]|||||||||C0030863|7994|7994|pentamidine
94	Pentamidine , itraconazole , Levaquin , acyclovir and GCSF were discontinued , along with other medications nonessential to patient &apos;s comfort .|itraconazole[10207,10219]|||||||||C0064113|28031|28031|itraconazole
94	Pentamidine , itraconazole , Levaquin , acyclovir and GCSF were discontinued , along with other medications nonessential to patient &apos;s comfort .|Levaquin[10222,10230]||||||||||217992|82122|levofloxacin
94	Pentamidine , itraconazole , Levaquin , acyclovir and GCSF were discontinued , along with other medications nonessential to patient &apos;s comfort .|acyclovir[10233,10242]|||||||||C0001367|281|281|acyclovir
94	Pentamidine , itraconazole , Levaquin , acyclovir and GCSF were discontinued , along with other medications nonessential to patient &apos;s comfort .|GCSF[10247,10251]||||||||||||
95	DNR / DNI status initially established early during hospital stay remained in effect .|DNR[10343,10346]||||||||||||
96	The patient was made comfortable with morphine for pain and for air hunger , and sinus suctioning was continued to relieve congestion , in conjunction with continuation of nasal sprays .|morphine[10468,10476]|||||||||C0026549|7052|7052|morphine
97	Tylenol was continued to control fevers and prednisone was continued to control inflammation and prevent precipitation of adrenal insufficiency .|Tylenol[10617,10624]||||||||||202433|161|paracetamol
97	Tylenol was continued to control fevers and prednisone was continued to control inflammation and prevent precipitation of adrenal insufficiency .|prednisone[10661,10671]|||||||||C0032952|8640|8640|prednisone
